Aspirin and mortality from coronary bypass surgery

被引：472

作者：

Mangano, DT ^{[1
]}

Saidman, L ^{[1
]}

Levin, J ^{[1
]}

Barash, P ^{[1
]}

Dietzel, C ^{[1
]}

Herskowitz, A ^{[1
]}

Ley, C ^{[1
]}

Hsu, P ^{[1
]}

Kardatzke, D ^{[1
]}

Wang, S ^{[1
]}

Tudor, IC ^{[1
]}

Beatty, D ^{[1
]}

Xavier, B ^{[1
]}

Kerkela, S ^{[1
]}

Aronson, S ^{[1
]}

Comunale, M ^{[1
]}

D'Ambra, M ^{[1
]}

Eaton, M ^{[1
]}

Engelman, R ^{[1
]}

Fitch, J ^{[1
]}

Grichnik, K ^{[1
]}

Hantler, CB ^{[1
]}

Hillel, Z ^{[1
]}

Kanchuger, M ^{[1
]}

Ostrowski, J ^{[1
]}

Mangano, CM ^{[1
]}

Mathew, J ^{[1
]}

Fontes, M ^{[1
]}

Barash, P ^{[1
]}

McSweeney, M ^{[1
]}

Wolman, R ^{[1
]}

Napolitano, CA ^{[1
]}

Nesbitt, LA ^{[1
]}

Nijhawan, N ^{[1
]}

Nussmeier, N ^{[1
]}

Pivalizza, EG ^{[1
]}

Polson, S ^{[1
]}

Ramsay, J ^{[1
]}

Roach, G ^{[1
]}

Schwann, N ^{[1
]}

Shenaq, S ^{[1
]}

Shevde, K ^{[1
]}

Shore-Lesserson, L ^{[1
]}

Bronheim, D ^{[1
]}

Wahr, J ^{[1
]}

Spiess, B ^{[1
]}

Wallace, A ^{[1
]}

Metzler, H ^{[1
]}

Ansley, D ^{[1
]}

O'Connor, JP ^{[1
]}

机构：

[1] Ischemia Res & Educ Fdn, Editorial Off, San Francisco, CA 94134 USA

来源：

NEW ENGLAND JOURNAL OF MEDICINE | 2002年 / 347卷 / 17期

关键词：

D O I：

10.1056/NEJMoa020798

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Background: There is no therapy known to reduce the risk of complications or death after coronary bypass surgery. Because platelet activation constitutes a pivotal mechanism for injury in patients with atherosclerosis, we assessed whether early treatment with aspirin could improve survival after coronary bypass surgery. Methods: At 70 centers in 17 countries, we prospectively studied 5065 patients undergoing coronary bypass surgery, of whom 5022 survived the first 48 hours after surgery. We gathered data on 7500 variables per patient and adjudicated outcomes centrally. The primary focus was to discern the relation between early aspirin use and fatal and nonfatal outcomes. Results: During hospitalization, 164 patients died (3.2 percent), and 812 others (16.0 percent) had nonfatal cardiac, cerebral, renal, or gastrointestinal ischemic complications. Among patients who received aspirin (up to 650 mg) within 48 hours after revascularization, subsequent mortality was 1.3 percent (40 of 2999 patients), as compared with 4.0 percent among those who did not receive aspirin during this period (81 of 2023, P<0.001). Aspirin therapy was associated with a 48 percent reduction in the incidence of myocardial infarction (2.8 percent vs. 5.4 percent, P<0.001), a 50 percent reduction in the incidence of stroke (1.3 percent vs. 2.6 percent, P=0.01), a 74 percent reduction in the incidence of renal failure (0.9 percent vs. 3.4 percent, P<0.001), and a 62 percent reduction in the incidence of bowel infarction (0.3 percent vs. 0.8 percent, P=0.01). Multivariate analysis showed that no other factor or medication was independently associated with reduced rates of these outcomes and that the risk of hemorrhage, gastritis, infection, or impaired wound healing was not increased with aspirin use (odds ratio for these adverse events, 0.63; 95 percent confidence interval, 0.54 to 0.74). Conclusions: Early use of aspirin after coronary bypass surgery is safe and is associated with a reduced risk of death and ischemic complications involving the heart, brain, kidneys, and gastrointestinal tract.

引用

页码：1309 / 1317

页数：9

共 44 条

[31] Platelet and neutrophil activation during cardiac surgical procedures: Impact of cardiopulmonary bypass [J].

Morse, DS ;

Adams, D ;

Magnani, B .

ANNALS OF THORACIC SURGERY, 1998, 65 (03) :691-695

[32]

Murray C.J.L., 1994, GLOBAL COMP ASSESSME

[33] Mortality by cause for eight regions of the world: Global Burden of Disease Study [J].

Murray, CJL ;

Lopez, AD .

LANCET, 1997, 349 (9061) :1269-1276

[34] OPTIMAL RISK FACTOR MANAGEMENT IN THE PATIENT AFTER CORONARY REVASCULARIZATION - A STATEMENT FOR HEALTH-CARE PROFESSIONALS FROM AN AMERICAN-HEART-ASSOCIATION WRITING GROUP [J].

PEARSON, T ;

RAPAPORT, E ;

CRIQUI, M ;

FURBERG, C ;

FUSTER, V ;

HIRATZKA, L ;

LITTLE, W ;

OCKENE, I ;

WILLIAMS, G .

CIRCULATION, 1994, 90 (06) :3125-3133

[35] MODULATION OF PLATELET SURFACE-ADHESION RECEPTORS DURING CARDIOPULMONARY BYPASS [J].

RINDER, CS ;

MATHEW, JP ;

RINDER, HM ;

BONAN, J ;

AULT, KA ;

SMITH, BR .

ANESTHESIOLOGY, 1991, 75 (04) :563-570

[36] Adverse cerebral outcomes after coronary bypass surgery [J].

Roach, GW ;

Kanchuger, M ;

Mangano, CM ;

Newman, M ;

Nussmeier, N ;

Wolman, R ;

Aggarwal, A ;

Marschall, K ;

Graham, SH ;

Ley, C ;

Ozanne, G ;

Mangano, DT .

NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (25) :1857-1863

[37]

ROYSTON D, 1987, LANCET, V2, P1289

[38] Hematocrit value on intensive care unit entry influences the frequency of Q-wave myocardial infarction after coronary artery bypass grafting [J].

Spiess, BD ;

Ley, C ;

Body, SC ;

Siegel, LC ;

Stover, EP ;

Maddi, R ;

D'Ambra, M ;

Jain, U ;

Liu, F ;

Herskowitz, A ;

Mangano, DT ;

Levin, J .

JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1998, 116 (03) :460-467

[39] Variability in transfusion practice for coronary artery bypass surgery persists despite national consensus guidelines - A 24-institution study [J].

Stover, EP ;

Siegel, LC ;

Parks, R ;

Levin, J ;

Body, SC ;

Maddi, R ;

D'Ambra, MN ;

Mangano, DT ;

Spiess, BD .

ANESTHESIOLOGY, 1998, 88 (02) :327-333

[40]

Taggart D P, 1990, Ann Thorac Surg, V50, P424

← 1 2 3 4 5 →